CRP and stroke disorder: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial aimed to assess potential benefits with respect to stroke occurrence in patients exhibiting a C-reactive protein (CRP) increase (>2 mg/L) and no hypercholesterolemia.